Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S331000, C514S357000, C546S229000, C546S234000, C546S330000, C546S339000
Reexamination Certificate
active
07872022
ABSTRACT:
The present invention relates to trans-derivatives of formulawherein R1, R2, R3, and the dotted line are as defined herein and to pharmaceutically acceptable acid addition salts thereof.The compounds of formula I are good inhibitors of the serotonin transporter (SERT inhibitors) and simultaneously, they have good activity on the NK-1 receptor (dual effect). By virtue of their efficacy as SERT inhibitors, the compounds in the present invention are particularly useful for the treatment of CNS disorders and psychotic disorders, in particular in the treatment or prevention of depressive states and/or in the treatment of anxiety.
REFERENCES:
patent: 5328917 (1994-07-01), Jakobsen et al.
patent: 6136824 (2000-10-01), Macleod et al.
patent: 6297375 (2001-10-01), Bös et al.
patent: 10008042 (2000-08-01), None
patent: WO 98/47514 (1998-10-01), None
patent: WO 01/29031 (2001-04-01), None
patent: WO 2003/015784 (2003-02-01), None
patent: WO 2005/032464 (2005-04-01), None
Froger et al., J. Neuroscience, vol. 21 (20), pp. 8188-8197 (2001).
Kramer et al., Science, vol. 281, pp. 1640-1645 (1998).
Millan et al., J. Neurochem. vol. 76, pp. 1949-1954 (2001).
Rupniak, N., Can. J. Physiol. Pharmacol. vol. 80, pp. 489-494 (2002).
Rupniak, N., Current Opinion in Investigational Drugs, vol. 3(2), pp. 257-261 (2002).
Ryckmans et al., Bioorg. Med. Chem. Lett. vol. 12(2), pp. 261-264 (2002).
Ryckmans et al., Bioorg Med. Chem. Lett. vol. 12(21), pp. 3195-3198 (2002).
Grundschober Christophe
Schnider Patrick
Chang Celia
Hoffmann-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
Serotonin transporter (SERT) inhibitors for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serotonin transporter (SERT) inhibitors for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serotonin transporter (SERT) inhibitors for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2676317